Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from FDA

Why Nauticus Robotics Shares Are Trading Higher By 96%; Here Are 67 Biggest Movers From Yesterday

Gainers Chardan NexTech Acquisition 2 Corp. (NASDAQ: CNTQ) shares surged 102.6% to close at $21.54 on Wednesday.

Benzinga

Three years after clinical trial, ketamine provides hope for severely depressed

LOS ANGELES -- Patients arriving at Dr. Philip O'Carroll's Newport Beach office for their first ketamine treatment are in pain and often lost. They have visited other doctors, tried other solutions and are ready for what is considered a last resort.

Los Angeles Times

Doctors urge U.S. FDA to add miscarriage management to abortion pill label

Obstetricians, gynecologists, other medical professionals, and abortion rights advocates petitioned the U.S. Food and Drug Administration (FDA) on Tuesday to urge Danco Laboratories to seek approval of mifepristone, a pill used in terminating early pregnancies at home, for miscarriage management.

Reuters

From analysis to the latest developments in health,
read the most diverse news in one place.

Why AeroClean Technologies Shares Are Trading Higher By Around 38%, Here Are 58 Stocks Moving In Tuesday's Mid-Day Session

Gainers Bit Brother Limited (NASDAQ: BTB) rose 229% to $0.3688 after declining around 14% on Monday.

Benzinga

Ice bucket challenge helps to fund FDA-approved motor neurone medication

Millions of dollars raised during the ice bucket challenge craze of 2014 have been used in the development of a new FDA-approved treatment.

The New Daily

Cheese sold at top supermarkets recalled

If you purchased cheese on a recent grocery run, here's everything you need to know to keep your kitchen safe

Salon

How McKinsey cashed in by consulting for both companies and their regulators

When McKinsey Comes to Town authors Walt Bogdanich and Michael Forsythe say the consulting firm helped companies boost tobacco and opioid sales — while at the same time working for the FDA.

WEKU

Read news from The Economist, FT, and more,
with one subscription

Woman shares photo of ‘mouldy’ breast implant that led to autoimmune disorder

‘I’m happy, healthy, and more importantly, extremely lucky to be able to get back to my normal self’

The Independent UK

Pharma-funded FDA gets drugs out faster, but some work only ‘marginally’ and most are pricey

Dr. Steven-Huy Han, a UCLA liver specialist, has prescribed Ocaliva to a handful of patients, although he’s not sure it helps.

Tribune News Service

Brie and camembert cheese recalled after listeria outbreak in six states

No deaths have been linked to listeria cases

The Independent UK

Why is corn syrup in infant formulas?

Nearly half of US infant formula contain corn sugars. Mounting evidence suggests it may not be the best for babies

Salon

ALS drug's approval draws cheers from patients, questions from skeptics

A controversial new drug for ALS could add months to patients' lives – if it actually works

WEKU

3 Safe Stocks You'll Want to Have Exposure to in 2022

The Fed’s aggressive monetary policies are raising recession fears. Amid such an environment, we think investors could consider adding AbbVie (ABBV), Pfizer (PFE), and Coca-Cola (KO) to their portfolios for stable returns. Read on to learn more….

StockNews.com

Why Carnival Shares Are Trading Lower By 19%, Here Are 49 Stocks Moving In Friday's Mid-Day Session

Gainers

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

US outlines plan for long-term baby formula imports

U.S. regulators have revealed their plan to allow foreign baby formula manufactures to stay on the market long term

The Independent UK

ALS drug wins FDA approval despite questionable data

U.S. health officials have approved a much-debated drug to treat the deadly illness known as Lou Gehrig's disease

Benzinga

PharmaTher Provides Business Highlights And Releases Audited Annual Financials

PharmaTher Holdings Ltd. (OTCQB: PHRRF) has published its operational and audited financial results for fiscal year ended May 31, 2022.

Reason

FDA Admits Vaping Is Safer Than Smoking But Refuses To Correct the Record

Don’t expect a change in course, despite the long-awaited admission.

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - UK

Civil service union urges honesty on public sector cuts amid austerity fears

Departments report being asked to find ways to reduce borrowing after Kwasi Kwarteng’s mini-budget

Axios

Another prospect for an Alzheimer's drug renews cost concerns

But positive clinical trial results also renew the hopes of millions of seniors.

Tribune News Service

This company is bioengineering pig kidneys and livers for possible transplant into humans

In an Minnesota lab, clear containers hold pig kidneys and livers that scientists hope will someday be transplantable in humans.

Benzinga

These Stocks Are On The Radar After Biogen-Eisai's Surprising Alzheimer's Trial Win

Eli Lilly And Co (NYSE:LLY) - Market cap: $295 billion.

Benzinga

FDA Finally Advances Cannabis Research & Regulations: Hires Ex-NY Cannabis Policy Regulator

The FDA has appointed Norman Birenbaum to be the its senior public health advisor on cannabis research and regulatory actions,

Benzinga

7 Biogen Analysts On Alzheimer's Drug Success As Stock Skyrockets 37%

Shares of Biogen Inc (NASDAQ: BIIB) were flying on Wednesday, after the biopharma company said its experimental Alzheimer’s drug with Japanese partner Eisai showed promising results. RBC Capital Markets On Biogen

Benzinga

Why MindMed Is Trading Lower By Around 35%; Here Are 31 Stocks Moving Premarket

Gainers Atlis Motor Vehicles Inc (NASDAQ: AMV) rose 211.7% to $256.00 in pre-market trading after jumping around 199% on Tuesday.

1 … 167 168 169 170

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.